684 related articles for article (PubMed ID: 15471506)
1. Use of selective serotonin reuptake inhibitors in children and adolescents.
Wong IC; Besag FM; Santosh PJ; Murray ML
Drug Saf; 2004; 27(13):991-1000. PubMed ID: 15471506
[TBL] [Abstract][Full Text] [Related]
2. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
[TBL] [Abstract][Full Text] [Related]
3. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
[TBL] [Abstract][Full Text] [Related]
4. Using acute tryptophan depletion to investigate predictors of treatment response in adolescents with major depressive disorder: study protocol for a randomised controlled trial.
Stewart RM; Hood SD; Rao P; Moore JK; Runions KC; Murphy SE; Wong JWY; Zepf FD
Trials; 2018 Aug; 19(1):434. PubMed ID: 30097056
[TBL] [Abstract][Full Text] [Related]
5. [Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
Bailly D
Presse Med; 2006 Oct; 35(10 Pt 2):1507-15. PubMed ID: 17028514
[TBL] [Abstract][Full Text] [Related]
6. [SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children].
Tandt H; Audenaert K; van Heeringen C
Tijdschr Psychiatr; 2009; 51(6):387-93. PubMed ID: 19517368
[TBL] [Abstract][Full Text] [Related]
7. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
Hjalmarsson L; Corcos M; Jeammet P
Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
[TBL] [Abstract][Full Text] [Related]
8. Newer generation antidepressants for depressive disorders in children and adolescents.
Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
[TBL] [Abstract][Full Text] [Related]
9. [Selective serotonin reuptake inhibitors (SSRI's) are not indicated for children and adolescents with depression].
Treffers PD; Rinne-Albers MA
Ned Tijdschr Geneeskd; 2005 Jun; 149(24):1314-7. PubMed ID: 16008032
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
11. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
12. How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?
Hall WD; Lucke J
Aust N Z J Psychiatry; 2006; 40(11-12):941-50. PubMed ID: 17054562
[TBL] [Abstract][Full Text] [Related]
13. [A place for SSRIs in the treatment of severely depressed children and adolescents].
Roobol TH; Buitelaar JK
Ned Tijdschr Geneeskd; 2008 Aug; 152(31):1710-2. PubMed ID: 18727599
[TBL] [Abstract][Full Text] [Related]
14. [Suicidality in depressive children and adolescents during treatment with selective serotonin reuptake inhibitors. Review and meta-analysis of the available randomised, placebo controlled trials].
Holtmann M; Bölte S; Poustka F
Nervenarzt; 2006 Nov; 77(11):1332-7. PubMed ID: 15986258
[TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review.
Gunnell D; Saperia J; Ashby D
BMJ; 2005 Feb; 330(7488):385. PubMed ID: 15718537
[TBL] [Abstract][Full Text] [Related]
16. The selective serotonin reuptake inhibitors controversy in the treatment of depression in children.
Weller EB; Tucker S; Weller RA
Curr Psychiatry Rep; 2005 Apr; 7(2):87-90. PubMed ID: 15802083
[TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis.
Jakobsen JC; Katakam KK; Schou A; Hellmuth SG; Stallknecht SE; Leth-Møller K; Iversen M; Banke MB; Petersen IJ; Klingenberg SL; Krogh J; Ebert SE; Timm A; Lindschou J; Gluud C
BMC Psychiatry; 2017 Feb; 17(1):58. PubMed ID: 28178949
[TBL] [Abstract][Full Text] [Related]
18. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries.
Rihmer Z; Akiskal H
J Affect Disord; 2006 Aug; 94(1-3):3-13. PubMed ID: 16712945
[TBL] [Abstract][Full Text] [Related]
19. [Drug treatment of depression in children and adolescents].
Grøholt B
Tidsskr Nor Laegeforen; 2011 Nov; 131(22):2243-5. PubMed ID: 22085951
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine: new indication. Depression in children: too many uncertainties.
Prescrire Int; 2008 Oct; 17(97):186-7. PubMed ID: 19534039
[No Abstract] [Full Text] [Related]
[Next] [New Search]
